Molecular and enzymatic analyses of lysosomal acid lipase in cholesteryl ester storage disease

被引:43
作者
Du, H [1 ]
Sheriff, S
Bezerra, J
Leonova, T
Grabowski, GA
机构
[1] Childrens Hosp, Med Ctr, Childrens Hosp Res Fdn, Div Human Genet, Cincinnati, OH 45229 USA
[2] Childrens Hosp, Med Ctr, Childrens Hosp Res Fdn, Div Gastroenterol & Nutr, Cincinnati, OH 45229 USA
[3] Univ Cincinnati, Coll Med, Cincinnati, OH 45229 USA
关键词
lysosomal acid lipase; Wolman's disease; cholesterol ester storage disease; immunoprecipitation;
D O I
10.1006/mgme.1998.2707
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Human lysosomal acid lipase (hLAL) is essential for the hydrolysis of cholesteryl esters and triglycerides in the lysosome. Defective hLAL activity leads to two autosomal recessive traits, Wolman disease (WD) or cholesteryl ester storage disease (CESD). Phenotypically, WD has accumulation of both triglycerides and cholesteryl esters, while CESD has mainly elevated cholesteryl esters. We characterized mutations in the hLAL gene from two CESD siblings. By reverse transcriptase-PCR (RT-PCR) and cDNA cloning and sequencing, we identified homozygous deletion mutations of nucleotides 863 to 934, in the hLAL; transcript. Normal levels of LAL mRNA were detected. The deletion in mRNA is due to a G to A transition in the last nucleotide of exon 8 of the hLAL gene, a splice junction mutation (E8SJM) that resulted in exon skipping, and a predicted in-frame deletion of the 24 amino acids. [S-35]Met metabolic labeling studies in fibroblasts showed a low level of E8SJM LAL (similar to 38%) that was highly unstable, Heterologous expression of E8SJM LAL in insect cells gave an LAL with low catalytic activity toward cholesteryl oleate and triolein. The effects of this mutation are complex with the production of decreased amounts of an unstable LAL that is catalytically defective. The results suggest that E8SJM leads to essentially a null allele and that the differences in WD and CESD phenotype involve Other factors. (C) 1998 Academic Press.
引用
收藏
页码:126 / 134
页数:9
相关论文
共 33 条
[1]   PURIFICATION, CHARACTERIZATION AND MOLECULAR-CLONING OF HUMAN HEPATIC LYSOSOMAL ACID LIPASE [J].
AMEIS, D ;
MERKEL, M ;
ECKERSKORN, C ;
GRETEN, H .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1994, 219 (03) :905-914
[2]  
AMEIS D, 1995, J LIPID RES, V36, P241
[3]  
ANDERSON RA, 1991, J BIOL CHEM, V266, P22479
[4]   INSITU LOCALIZATION OF THE GENETIC-LOCUS ENCODING THE LYSOSOMAL ACID LIPASE CHOLESTERYL ESTERASE (LIPA) DEFICIENT IN WOLMAN-DISEASE TO CHROMOSOME-10Q23.2-Q23.3 [J].
ANDERSON, RA ;
RAO, N ;
BYRUM, RS ;
ROTHSCHILD, CB ;
BOWDEN, DW ;
HAYWORTH, R ;
PETTENATI, M .
GENOMICS, 1993, 15 (01) :245-247
[5]   MUTATIONS AT THE LYSOSOMAL ACID CHOLESTERYL ESTER HYDROLASE GENE LOCUS IN WOLMAN-DISEASE [J].
ANDERSON, RA ;
BYRUM, RS ;
COATES, PM ;
SANDO, GN .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (07) :2718-2722
[6]   GENOMIC ORGANIZATION OF THE HUMAN LYSOSOMAL ACID LIPASE GENE (LIPA) [J].
ASLANIDIS, C ;
KLIMA, H ;
LACKNER, KJ ;
SCHMITZ, G .
GENOMICS, 1994, 20 (02) :329-331
[7]   Genetic and biochemical evidence that CESD and Wolman disease are distinguished by residual lysosomal acid lipase activity [J].
Aslanidis, C ;
Ries, S ;
Fehringer, P ;
Buchler, C ;
Klima, H ;
Schmitz, G .
GENOMICS, 1996, 33 (01) :85-93
[8]  
Assmann G, 1995, METABOLIC MOL BASES, P2563
[9]  
BRIGGS MR, 1993, J BIOL CHEM, V268, P14490
[10]  
BROWN MS, 1980, J LIPID RES, V21, P505